Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07388147

Exercise Therapy for Multiple Myeloma Patients

Structural Measures for Multiple Myeloma Patients to Improve Rehabilitation by Exercise Therapy

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
71 (estimated)
Sponsor
University Hospital Heidelberg · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Physical exercise is an important supportive therapy for cancer patients, as it improves quality of life in general and might mitigate the side effects of drug treatment. For patients with multiple myeloma in particular, significantly less evidence on the effectiveness of exercise therapy is available due to the fact that this disease is associated with severe bone degradation which might affect bone stability. Advances in oncologic drug treatment have improved overall survival in multiple myeloma significantly. Therefore, there is an increased interest for recommendations on physical activity in this patient group. Due to uncertainties regarding safety and feasibility of exercise therapy in multiple myeloma, both patients and therapists often remain hesitant. Therefore, an orthopaedic outpatient clinic has been established at the Myeloma Center of Heidelberg University Hospital. Here, patients receive consultation on bone stability and individualized physical exercise plans. Based on the expertise gained at the orthopaedic outpatient clinic, the aim of this study is to establish and evaluate structural measures for improved rehabilitation in multiple myeloma and to integrate them into routine clinical care.

Conditions

Interventions

TypeNameDescription
OTHEROrthopedic consultation and rehabilitation by excercise therapyAll patients will receive a continuous orthopaedic consultation on bone stability and recommendations for exercise therapy during the different phases of systemic myeloma therapy. Thereby, structural measures to improve rehabilitation in multiple myeloma will be established and evaluated with the intention of integrating them into routine clinical care.

Timeline

Start date
2026-03-01
Primary completion
2029-03-31
Completion
2029-03-31
First posted
2026-02-04
Last updated
2026-02-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT07388147. Inclusion in this directory is not an endorsement.